MedTrace Logo

DEXA Bone Density Analysis of the CoreHip® Prosthesis System

NCT06632301 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-02-27

No results posted yet for this study

Summary

The goal of this interventional post-market follow-up study is to evaluate radiological changes in the diaphyseal bone density (Gruen Zones 3 and 4) within 24 months postoperative in patients treated with CoreHip® primary cementless stem. The DEXA bone density analysis is used.

Conditions

  • Primary Osteoarthritis
  • Cartilage Degeneration
  • Osteoarthritis, Hip
  • Inflammatory Arthritis
  • Osteonecrosis of Femoral Head
  • Traumatic Disorder

Interventions

DEVICE

Primary hip replacement with cementless stem

Total Hip Arthroplasty is today one of the most established surgical orthopaedic procedures worldwide.

Sponsors & Collaborators

  • Aesculap AG

    lead INDUSTRY

Principal Investigators

  • Henning Windhagen, Prof. Dr. · Orthopädische Kliniken im Annastift, MHH

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2027-09-30
Completion
2028-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06632301 on ClinicalTrials.gov